Meridian to market E coli rapid test in US:
This article was originally published in Clinica
Executive Summary
Meridian Diagnostics will market its ImmunocardStat! E coli 0157 Plus rapid test in the US. The test determines whether E Coli is the cause of gastroenteric-related disease in ten minutes. The Cincinnati, Ohio-based company claims prompt diagnosis of the infection can reduce healthcare costs, by preventing acute renal failure and haemolytic uraemic syndrome, brought on by the toxins generated by the bacterium.